 |
|
|
| |
Paediatric Pharmacokinetic-Pharmacodynamic Extrapolation to
Identify Suitable Bulevirtide Doses for Children and
Adolescents With Chronic Hepatitis Delta
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Parag Kumar1,a, Anna M Mc Laughlin2,a, Nieves Velez de Mendizabal1, Luzelena Caro1, Kathryn Kersey1, Carolina Iglesias-Lopez3, Joanna Koziara1, Ana Ruiz-Garcia1
1Gilead Sciences, Inc., Foster City, CA, USA; 2Pharmetheus AB, Uppsala, Sweden; 3Gilead Sciences, Inc., UC Dublin Central, Dublin, Ireland
aAuthors contributed equally
|
| |
|
|
|
|
|
